This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
This page refreshes automatically every 30 mins. Press F5 to update manually
For a more detailed explanation of Upgrades/Downgrades see Link
Key: (?) = Upgraded, (?) = Downgraded, (-) = Maintained
| Stock | Broker Update |
| Arm Holdings | Deutsche Bank downgrades to Hold from Buy; cuts TP to 1070P from 1130P |
| Associated British Foods | Berenberg ups TP to 2,600p from 1,960p, Hold |
| Astrazeneca | Jefferies ups to Hold from underperform; ups TP to 3080p |
| BTG | Jefferies ups TP to 525p from 420p, Hold |
| Centrica | Raymond James cuts TP to 312p from 327p, underperform |
| CRH | UBS ups to Buy from neutral; ups TP to 1740p from 1580p |
| Glaxosmithkline | Jefferies ups TP to 1750p from 1700p, Hold |
| Interserve | JP Morgan ups TP to 708p from 660p, overweight |
| J Sainsbury | JP Morgan cuts TP to 340p from 380p, underweight |
| Ladbrokes | Barclays downgrades to underweight from Equalweight; cuts TP to 169p from 188p |
| Mothercare | UBS cuts TP to 330p from 420p, neutral |
| Mothercare | Liberum cuts TP to 160p from 300p, sell |
| Mothercare | JP Morgan downgrades to neutral from overweight; TP to 335p from 450p |
| Persimmon | Deutsche Bank ups TP to 1366p from 1310p |
| Petroceltic | Liberum downgrades to Hold from Buy |
| Restaurant Group | Panmure ups TP to 684p from 600p, Buy |
| Spirit Pub Company | Citi group ups TP to 95P from 75p, Buy |
| Unilever | Berenberg downgrades to Hold from Buy; TP to 2700p from 2900p |
| William Hill | Barclays downgrades to Equalweight from overweight; cuts TP to 420p from 440p |
| Source: Reuters News, AlphaTerminal, Dow Jones Newswires | |
Source: Bloomberg, Reuters News, AlphaTerminal, Dow Jones Newswires
T111his research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research